Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Comment by mstrmndon Mar 11, 2021 4:41pm
176 Views
Post# 32778570

RE:Email Antibe and Demand CEO be Fired!!

RE:Email Antibe and Demand CEO be Fired!!Got to light a fire under Dan, if retail investors are not going to get paid now, then c-ya Danny boy!! 

Mass emails from retail shareholders are very powerful when Dan's on the chopping block for this entire mess of trying to hide very positive results to a spectacular pipeline...Dan if you're trying to be everyone's friend (Echelon, Canaccord) to create win-win-win's on the back's of retail investors that have supported Antibe, you're dunzo and so are they!!  

WHERE'S THE MONEY ECHELON???

I better see Dan put all that money he took out last year back in otherwise LAWSUIT COMING for triggering a slide on a handshake deal with Echelon to open market at $0.89 on 2b results to cheat retail investors on selling pressure to line up Dan at $0.60, and to land at $0.40 for Echelon when it was a TOTAL inside job!!

This old guy is whack!! This is classic OLD WHITE money behaviour!!

Firing Dan is NOT enough, he needs to be investigated on ties to Echelon & Co.

WHERE'S OUR MONEY DAN??  


mstrmnd wrote: Old boys club at Echelon and Canaccord getting rich off retail investors HUH??  

Email Antibe and demand CEO be fired!!

Dan - get out of the way and stop trying to get yourself and friends & co rich...your job is done and you've done way too much damage, in fact, so much damage that it's very suspicious...in bed with Echelon and Canaccord HUH??

Dan is a nasty skid mark that just won't go away to a company that does NOT need him and longstanding friendship to John is an indefensible reason to be CEO 

Dan sold the farm for pennies on the dollar to the old boys club to get the entire town rich!!! 

If they fire Dan i'll drop another $500K that exact day...


<< Previous
Bullboard Posts
Next >>